Xarelto Lawsuits in Ohio
Turn to Our Cleveland Dangerous Drug Lawyers
Spangenberg Shibley & Liber LLP is investigating cases of uncontrolled bleeding in connection with the medication Xarelto, which can cause serious and fatal bleeding.
Xarelto is an anti-clotting drug that was approved in November 2011 by the FDA to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation and to help prevent deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE) in patients undergoing knee or hip replacement surgery.
However, unlike older anticoagulants that had to be prescribed in specific does for each patient, doctors could only give uniform doses of Xarelto to individuals. This is because it is a new type of oral anticoagulant that comes in singular doses. This opens the door for more issues and side effects, as each patient’s body and condition may require varying dose levels of any drug.
Symptoms of Xarelto Use
Xarelto is a once-daily pill that Johnson & Johnson, through its Janssen Pharmaceuticals subsidiary, developed with Bayer AG. Xarelto was designed to sidestep risks of warfarin, including brain hemorrhages and other dangerous bleeding, and become mainstays of a new therapeutic market worth at least $10 billion a year. Patients taking warfarin require close monitoring and regular blood tests as well as dietary and lifestyle changes. Xarelto is marketed as being a drug for which no regular blood tests or monitoring is required.